Pulmonary Disease, Chronic Obstructive: all 4,252 studies

Page 34 of 43. Open to participants first (707), then studies with results posted, then the rest; newest registration first within each.

• Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD ExacerbationsCompletedNCT01865500Phase 4
• IN UTERO SMOKING AND PREMATURE CELLULAR SENESCENCECompletedNCT01865435Not applicable
• A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPDWithdrawnNCT01860066Phase 3
• Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ERCompletedNCT01857947Not applicable
• Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01855230Phase 2
• A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice ResponseCompletedNCT01855022Not applicable
• Urban Walking CircuitsCompletedNCT01854008Not applicable
• Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB StudyCompletedNCT01853787Phase 4
• Effectiveness of Influenza Vaccine Reminder SystemsCompletedNCT01852656Not applicable
• Abdominal Binding in Chronic Obstructive Pulmonary DiseaseCompletedNCT01852006Not applicable
• Whole Body Vibration in Chronic Obstructive Pulmonary DiseaseCompletedNCT01850173Not applicable
• Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once DailyCompletedNCT01849341Phase 4
• Efficacy of NVA237 (50 μg o.d) Using Tiotropium (5μg μg o.d) as Active Control in COPD Patients.WithdrawnNCT01837927Phase 3
• A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD PatientsStatus unknownNCT01836016Phase 3
• A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPDWithdrawnNCT01834885Phase 3
• Physiotherapy in Exacerbation Chronic Obstructive Pulmonary DiseaseCompletedNCT01826682Not applicable
• Chest Wall Muscle Stretching and Acute Effects in Chronic Obstructive Pulmonary DiseaseCompletedNCT01826669Not applicable
• Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary DiseasesCompletedNCT01825538
• Pulmonary Disease in a Psychiatric Inpatient PopulationCompletedNCT01823627Not applicable
• Bacterial Colonization in COPD in View of CAT Under ICS+LABA TherapyCompletedNCT01819298
• Does Pulmonary Rehabilitation Improve Breathing of COPD PatientsWithdrawnNCT01815970Not applicable
• Progressive Resistance Training of the Extensor Muscle of the Thigh in COPD-patients Hospitalized With an ExacerbationWithdrawnNCT01812460Not applicable
• Benefits Study of Respiratory-gated PET Acquisition in Lung DiseaseCompletedNCT01812031Not applicable
• Using NT-proBNP to Detect Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01801722
• Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD ExacerbationCompletedNCT01798420
• Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)CompletedNCT01797367
• Handling Inhalers - Technique Error Comparison (HI-TEC)CompletedNCT01794390
• A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy SubjectsTerminatedNCT01793649Phase 1
• Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic BronchitisCompletedNCT01792271Not applicable
• The Role of Resistance Exercise in Chronic Obstructive Pulmonary Disease ExacerbationCompletedNCT01786928Not applicable
• COPD Research RegistryCompletedNCT01785706
• The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up StudyStatus unknownNCT01785537
• To Compare the Pharmacokinetics of Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01785433Phase 1/2
• Comparative Effects of Different Noninvasive Ventilation Mode on Neural Respiratory Drive in Recovering AECOPD PatientsCompletedNCT01782768Not applicable
• Summer-Winter Variability in the Level of Physical Activity in Daily Life in Brazilian and Belgian Patients With COPDStatus unknownNCT01779960
• Effects of an Air Purifying Device (PureNight) on Sleep Quality in Obstructive Lung DiseaseCompletedNCT01772342Not applicable
• Walking Speeds in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01768754
• Asthma & COPD Guideline ImplementationTerminatedNCT01766544Early Phase 1
• WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNCT01763463
• Influence of Bag Volume Variation on the Reproducibility of Inert Gas RebreathingCompletedNCT01762917
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy SubjectsCompletedNCT01762878Phase 1
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese SmokersCompletedNCT01762774Phase 1
• Evaluation of FeNO During and Following Acute COPD ExacerbationTerminatedNCT01761006
• The Six-minute Stepper Test as an Outcome Measure of Exercise Tolerance During Pulmonary Rehabilitation in With Chronic Obstructive Pulmonary Disease (COPD) Patients(STEPPER)?CompletedNCT01759199Not applicable
• Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICSWithdrawnNCT01757015Phase 3
• A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy SubjectsCompletedNCT01754844Phase 1
• Perception of Symptom Variability in COPDCompletedNCT01753427
• Study of Chronic Obstructive Pulmonary Disease (COPD) Exacerbations In SpainCompletedNCT01750658
• Muscle Dysfunction in Patients With Chronic Obstructive Lung Disease (COPD): the Role of Sympathetic ActivationCompletedNCT01750489Not applicable
• Oxis 9mcg Turbuhaler Clinical Experience InvestigationCompletedNCT01749462
• The Effects of Atorvastatin Treatment in COPD PatientsCompletedNCT01748279Phase 4
• Prevalence of Different Haptoglobin Phenotypes in Patients With COPD- Frequent Exacerbators Versus Non ExacerbatorsCompletedNCT01745419
• Compare the Effect of a Remote Monitoring System Using the EXACT Tool to Reduce Hospitalizations Due to Chronic Obstructive Pulmonary Disease (COPD) Exacerbations. EXACT = Exacerbations of Chronic Pulmonary Disease Tool.CompletedNCT01744028Phase 1
• Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01734473Not applicable
• Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPDCompletedNCT01728220Phase 2
• Self-care Program in the Prevention of Admissions of PatientsStatus unknownNCT01726244Not applicable
• Feasibility and Effectiveness of Telehealth in Patients With Chronic Obstructive Pulmonary Disease in TaiwanStatus unknownNCT01724684Not applicable
• Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary DiseaseCompletedNCT01719822Not applicable
• Morphine, Dyspnea, Exercise and COPDStatus unknownNCT01718496Phase 3
• Efficacy of Vakum Technology in Patients With Chronic HypersecretionStatus unknownNCT01718067Not applicable
• Evaluation of the IPS System for TLD Therapy in Patients With COPDCompletedNCT01716598Phase 1
• Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum SymptomCompletedNCT01715493Phase 4
• Effects of Rehabilitation on Muscle Fibre Composition and Capillaries in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01715337Not applicable
• Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active ControlWithdrawnNCT01715311Phase 4
• Proteasis Evaluation in COPDCompletedNCT01713335
• Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01713075
• Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With OxygenCompletedNCT01710449Phase 1
• Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01703624Phase 2
• Correlation Between Patient Perception and Findings on Clinical Examination in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01703416
• Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)CompletedNCT01703052Phase 1
• Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary DiseaseTerminatedNCT01701934Phase 2
• Microbiology & Immunology of the Chronically-inflamed AirwayCompletedNCT01701869
• Prognosis and Treatment of COPD in Primary Care-use of BiomarkersStatus unknownNCT01698151
• Development of the Partial Pressure of Carbon Dioxide During Exercise and at Night in Patients With Chronic Obstructive Pulmonary Disease (COPD) IVCompletedNCT01696916Not applicable
• Feel Breathe, Restriction Device Ventilatory Nasal (COPD)CompletedNCT01695265Not applicable
• Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary DiseaseCompletedNCT01694732Phase 3
• Indacaterol Versus Tiotropium on Dynamic Hyperinflation in COPDCompletedNCT01693003Phase 4
• Role of Fibrocytes in the Bronchial Remodelling of Chronic Obstructive Pulmonary DiseaseCompletedNCT01692444Not applicable
• A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy SubjectsCompletedNCT01691547Phase 1
• Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal VolunteersCompletedNCT01690949Phase 1
• Research to Evaluate a Possible Relation Between Values Obtained After Processing CT Images, Lung Function Tests and the Experience of the Patient During an Exacerbation in COPD Patients.CompletedNCT01684384Not applicable
• Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With COPDCompletedNCT01682447Not applicable
• Involvement of Nervous System in Muscle Weakness in COPD PatientsCompletedNCT01679782
• Effects of IPV Assessed With Functional ImagingStatus unknownNCT01671540Not applicable
• Effects of Sulfur Thermal Water Inhalation on Airway Oxidative Stress in COPD PatientsCompletedNCT01664767Not applicable
• The Effect of Humidification on Mucus RheologyCompletedNCT01661374
• Effects of Neuromuscular Electrical Stimulation as an Adjunct to Exercise Training in Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01658046Not applicable
• Assessment of Risk in Chronic Airways Disease EvaluationCompletedNCT01656421
• Beta Blocker Therapy in Moderate to Severe COPDCompletedNCT01656005Phase 4
• Comorbidities and Healthcare Utilisation: Indicators for Improving COPD DiagnosisCompletedNCT01655667
• Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary DiseaseStatus unknownNCT01655199Not applicable
• Comparative Study of 3 Portable Oxygen Concentrators During a 6-minute Walk Test in Patients With Chronic Lung DiseaseCompletedNCT01653730Not applicable
• Estimation of the VQ11 Auto-questionnaire, to Follow Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01651676Not applicable
• HELPing Older People With Very Severe Chronic Obstructive Pulmonary Disease Towards the End of Their Lives: Developing, Piloting and Refining a Practical Intervention (HELP-COPD)CompletedNCT01650480Early Phase 1
• Whole Body Vibration in Chronic Obstructive Pulmonary Disease (COPD) PatientsStatus unknownNCT01649310Not applicable
• Program of Integrated Care for Patients With Chronic Obstructive Pulmonary Disease and Multiple ComorbiditiesCompletedNCT01648621Not applicable
• Validation of Questionnaire and Assessment of Patient Satisfaction for Budesonide/Formoterol Fix Combination Dry Powder Inhalers (DPI) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01646424
• Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled StudyCompletedNCT01645800Phase 4
• Helmet Ventilation in Acute Hypercapnic Respiratory FailureCompletedNCT01645358Phase 4
• "Consultation Liaison and Integrated Care for COPD Patients With Psychiatric Co-Morbidity"CompletedNCT01644916Not applicable

← Pulmonary Disease, Chronic Obstructive overview